Living Anisotropic Structural Color Hydrogels for Cardiotoxicity Screening

A β-cyclodextrin-based supramolecular photonic crystal hydrogel biosensor with macroporous structures for naked-eye visual detection of cholesterol

Cholesterol (CHO) is an essential lipid in cell membranes and a precursor for vital living substances. Abnormal CHO levels can cause cardiovascular diseases. Therefore, simple and accurate monitoring of CHO levels is crucial for early diagnosis and effective management of cardiovascular diseases. Herein, we report a β-cyclodextrin-based supramolecular photonic crystal hydrogel (PCH) biosensor for naked-eye visual CHO detection. This sensor is composed of a poly(acrylamide-co-N-isopropylacrylamide-co-maleic anhydride-β-cyclodextrin) smart hydrogel with embedding Fe3O4 colloidal chains, which can translate CHO concentration signals into visually detectable color changes of the hydrogel. By carefully selecting a macromolecular crosslinker, a macroporous structure of the hydrogel was achieved, significantly enhancing CHO responsiveness. Molecular docking provides detailed information about the binding mode between MAH-β-CD and CHO. The cyclohexanol portion and alkyl chain of CHO molecule are inserted into MAH-β-CD cavity, driven primarily by hydrophobic interactions. Moreover, this sensor demonstrates excellent regenerability and could be facilely regenerated by washing using hot/cold water or acid solution. Furthermore, it is highly selective for CHO and is suitable for detecting actual human serums. Such a β-CD-based supramolecular PCH biosensor with visualization, excellent regenerability, and high sensitivity and selectivity toward CHO, provides a basis for clinical diagnosis of diseases relative to CHO abnormalities.

Glucose oxidase: An emerging multidimensional treatment option for diabetic wound healing

The healing of diabetic skin wounds is a complex process significantly affected by the hyperglycemic environment. In this context, glucose oxidase (GOx), by catalyzing glucose to produce gluconic acid and hydrogen peroxide, not only modulates the hyperglycemic microenvironment but also possesses antibacterial and oxygen-supplying functions, thereby demonstrating immense potential in the treatment of diabetic wounds. Despite the growing interest in GOx-based therapeutic strategies in recent years, a systematic summary and review of these efforts have been lacking. To address this gap, this review article outlines the advancements in the application of GOx and GOx-like nanozymes in the treatment of diabetic wounds, including reaction mechanisms, the selection of carrier materials, and synergistic therapeutic strategies such as multi-enzyme combinations, microneedle structures, and gas therapy. Finally, the article looks forward to the application prospects of GOx in aiding the healing of diabetic wounds and the challenges faced in translating these innovations to clinical practice. We sincerely hope that this review can provide readers with a comprehensive understanding of GOx-based diabetic treatment strategies, facilitate the rigorous construction of more robust multifunctional therapeutic systems, and ultimately benefit patients with diabetic wounds.

Flexible Inverse Opal Structural Color Films with High Strength and Harsh Environment Stability

Flexible photonic crystals (PCs) constructed by PCs and special polymers are very promising to achieve a combination of vivid structural colors, mechanical robustness, and environment stability. However, PCs that incorporate polymer binders are still susceptible to destruction and subsequent loss of structural color when subjected to significant external forces or harsh environments. Besides, because most of these polymers are highly flammable, crucial fire safety is difficult to be guaranteed in the application of these materials. In this study, we report a poly(m-phenyleneisophthalamide) inverse opal (PMIA IO) structural color film through a SiO2 PC template sacrificing method. Benefiting from the high rigid PMIA molecular structural configuration, the PMIA IO films are able to maintain their structural colors even in harsh conditions, such as large tensile stress, high and low temperatures, potent acids and bases, and ultraviolet radiation. More attractively, the PMIA IO films demonstrate excellent flame retardancy, with the limiting oxygen index (LOI) and flame retardant rating reaching 28 vol % and V0, respectively. We believe that the flexible structural color films with high strength, harsh environment stability, and flame retardancy, which are difficult for other structural color materials to possess simultaneously, have great potential for special applications in fire protection, national defense, aviation, marine, and aerospace fields.

Blue Laser Triggered Hemostatic Peptide Hydrogel for Gastrointestinal Bleeding Treatment

In an emergency, nonvariceal upper gastrointestinal bleeding (NVUGIB), endoscopic hemostasis is considered the gold standard intervention. However, current endoscopic hemostasis is very challenging to manage bleeding in large-diameter or deep lesions highly prone to rebleeding risk. Herein, a novel hemostatic peptide hydrogel (HPH) is reported, consisting of a self-assembly peptide sequence CFLIVIGSIIVPGDGVPGDG (PFV) and gelatin methacryloyl (GelMA), which can be triggered by blue laser endoscopy (BLE) for nonvariceal upper gastrointestinal bleeding treatment without recurring bleeding concerns. Upon contact with GelMA solution, PFV immediately fibrillates into β-sheet nanofiber and solvent-induced self-assembly to form HPH gel. HPH nanofiber networks induced ultrafast coagulation by enveloping blood cells and activating platelets and coagulation factors even to the blood with coagulopathy. Besides its remarkable hemostatic performance in artery and liver injury models, HPH achieves instant bleeding management in porcine NVUGIB models within 60 s by preventing the rebleeding risk. This work demonstrates an extraordinary hemostatic agent for NVUGIB intervention by BLE for the first time, broadening potential application scenarios, including patients with coagulopathy and promising clinical prospects.

Developing organs-on-chips for biomedical applications

In recent years, organs-on-chips have been arousing great interest for their bionic and stable construction of crucial human organs in vitro. Compared with traditional animal models and two-dimensional cell models, organs-on-chips could not only overcome the limitations of species difference and poor predict ability but also be capable of reappearing the complex cell-cell interaction, tissue interface, biofluid and other physiological conditions of humans. Therefore, organs-on-chips have been regarded as promising and powerful tools in diverse fields such as biology, chemistry, medicine and so on. In this perspective, we present a review of organs-on-chips for biomedical applications. After introducing the key elements and manufacturing craft of organs-on-chips, we intend to review their cut-edging applications in biomedical fields, incorporating biological analysis, drug development, robotics and so on. Finally, the emphasis is focused on the perspectives of organs-on-chips.

The new era of cardiovascular research: revolutionizing cardiovascular research with 3D models in a dish

Cardiovascular research has heavily relied on studies using patient samples and animal models. However, patient studies often miss the data from the crucial early stage of cardiovascular diseases, as obtaining primary tissues at this stage is impracticable. Transgenic animal models can offer some insights into disease mechanisms, although they usually do not fully recapitulate the phenotype of cardiovascular diseases and their progression. In recent years, a promising breakthrough has emerged in the form of in vitro three-dimensional (3D) cardiovascular models utilizing human pluripotent stem cells. These innovative models recreate the intricate 3D structure of the human heart and vessels within a controlled environment. This advancement is pivotal as it addresses the existing gaps in cardiovascular research, allowing scientists to study different stages of cardiovascular diseases and specific drug responses using human-origin models. In this review, we first outline various approaches employed to generate these models. We then comprehensively discuss their applications in studying cardiovascular diseases by providing insights into molecular and cellular changes associated with cardiovascular conditions. Moreover, we highlight the potential of these 3D models serving as a platform for drug testing to assess drug efficacy and safety. Despite their immense potential, challenges persist, particularly in maintaining the complex structure of 3D heart and vessel models and ensuring their function is comparable to real organs. However, overcoming these challenges could revolutionize cardiovascular research. It has the potential to offer comprehensive mechanistic insights into human-specific disease processes, ultimately expediting the development of personalized therapies.

Highly Electroactive Tissue Engineering Scaffolds Based on Nanocellulose/Sulfonated Carbon Nanotube Composite Hydrogels for Myocardial Tissue Repair

Myocardial infarction (MI) has been a serious threat to the health of modern people for a long time. The introduction of tissue engineering (TE) therapy into the treatment of MI is one of the most promising therapeutic schedules. Considering the intrinsic electrophysiological activity of cardiac tissue, we utilized 2,2,6,6-tetramethylpiperidinyl-1-oxyl (TEMPO)-oxidized cellulose nanofibrils (TOCNs) with excellent biocompatibility as the substrate, and sulfonated carbon nanotubes (SCNTs) with remarkable conductivity and water dispersibility as the electrically active material, to prepare TOCN-SCNT composite hydrogels. By adjusting the content of SCNTs from 0 to 5 wt %, TOCN-SCNT hydrogels exhibited conductivity ranging from 5.2 × 10-6 to 6.2 × 10-2 S cm-1. Just with 1 wt % incorporation of SCNTs, the hydrogel played a role in promoting the adhesive growth and proliferation of cells. The hydrogel expressed higher Connexin 43 (Cx-43) and cardiac troponin-T proteins compared with controls, demonstrating great potential in constructing a myocardial TE scaffold.